close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

50.45 +0.90 (+1.82%)
Official Closing Price Updated: 1:15 PM EST, Nov 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Soleno Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Tesla To $455? Here Are 10 Top Analyst Forecasts For Monday ↗
 
Via Benzinga
News headline image
Soleno Shares Are Up Today: What's Going On? ↗
Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares are trading higher Thursday after the company announced it secured FDA approval for its first commercial drug, Vykat XR (diazoxide choline)... 
Via Benzinga
News headline image
Top stock movements in today's session. ↗
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Soleno Therapeutics Stock Is Skyrocketing Today ↗
The clinical-stage biotech company received great news from the FDA. 
Via The Motley Fool
Soleno Therapeutics Inc. (NASDAQ: SLNO) is a Stock Spotlight on 2/22
Via Investor Brand Network
Soleno Therapeutics Inc. (NASDAQ: SLNO) is a Stock Spotlight on 2/20
Via Investor Brand Network
News headline image
Which stocks are gapping on Thursday? ↗
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
News headline image
Gold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results ↗
 
Via Benzinga
News headline image
Top movers in Thursday's pre-market session ↗
Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
Concentrix Posts Better-Than-Expected Earnings, Joins Soleno Therapeutics, Petco Health and Wellness, MillerKnoll And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Soleno Surges Into Breakout On Hard-Won Obesity-Tied Approval, Pulling Aardvark Higher ↗
The drug treats excessive hunger that often leads to obesity in patients with a rare, genetic disease. 
Via Investor's Business Daily
News headline image
Behind the Scenes of Soleno Therapeutics's Latest Options Trends ↗
 
Via Benzinga
News headline image
Soleno Therapeutics Stock Rockets 34% Pre-Market After FDA Approves Prader-Willi Syndrome Drug: Retail Sentiment Peaks ↗
The company expects the drug, the first approved therapy to address hyperphagia in PWS patients, to be available in the U.S. starting April 2025. 
Via Stocktwits
News headline image
Soleno Therapeutics Secures FDA Approval For Its First Commercial Drug For Rare Genetic Disorder ↗
Soleno's Vykat XR wins FDA approval as the first treatment for hyperphagia in Prader-Willi syndrome, with U.S. availability expected by April 2025. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
US Stocks Likely To Open Mixed: 'Expect Volatility. Buckle Up,' Says Expert ↗
U.S. stock futures were swinging between gains and losses on Thursday after snapping a three-day winning streak on Wednesday. Futures of major benchmark indices were mixed in premarket trading. Aiming... 
Via Benzinga
Topics Supply Chain World Trade
News headline image
Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Why Soleno Therapeutics Stock Blasted 9% Higher Today ↗
The company's Prader-Willi treatment inched closer to FDA approval. 
Via The Motley Fool
News headline image
PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Hain Celestial Posts Upbeat Q4 Earnings, Joins Soleno Therapeutics, Energizer Holdings And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
SLNO Stock Earnings: Soleno Therapeutics Beats EPS for Q2 2024 ↗
SLNO stock results show that Soleno Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker ↗
NVIDIA Corp. (NASDAQ:NVDA) has been the standout tech stock of the past year, leading the Nasdaq 100 index in the performance ranking. 
Via Benzinga
Topics Artificial Intelligence
News headline image
SLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q1 2024 ↗
SLNO stock results show that Soleno Therapeutics missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday? ↗
U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc.... 
Via Benzinga
News headline image
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
SLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q4 2023 ↗
SLNO stock results show that Soleno Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today